The Clinical Significance of Molecular Markers to Bladder Cancer-Reference-Cited by-同舟云学术

The Clinical Significance of Molecular Markers to Bladder Cancer

Published:2004-12 Issue:6 Volume:23 Page:335-342
ISSN:1536-8599
Container-title:Hybridoma and Hybridomics
language:en
Short-container-title:Hybridoma and Hybridomics

Author:

Syrigos Konstantinos N.¹²,Karapanagiotou Eleni¹,Harrington Kevin J.²

Affiliation:

1. Oncology Unit, 3rd Department of Medicine, Athens Medical School, Sotiria General Hospital, Athens, Greece.

2. Cancer Research Centre for Cell and Molecular Biology, Chester Beatty Laboratories, Institute of Cancer Research, Royal Marsden NHS Trust Hospitals, London, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/hyb.2004.23.335

Reference80 articles.

1. PROGNOSTIC MARKERS IN BLADDER CANCER: A CONTEMPORARY REVIEW OF THE LITERATURE

2. EDITORIAL

3. Cytologic spectrum of bladder cancer

4. Expression ofc-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urothelial carcinoma associated with Balkan endemic nephropathy. A worldwide disease;Pathologie Biologie;2011-10

2. Intervention of nicotine on MNU-induced bladder cancer in rats;Journal of Huazhong University of Science and Technology [Medical Sciences];2011-02

3. Bladder Cancer-associated Protein, a Potential Prognostic Biomarker in Human Bladder Cancer;Molecular & Cellular Proteomics;2010-01

4. Carcinogenetic Pathway of Urothelial Carcinoma;Mechanisms of Oncogenesis;2010

5. Roles of estrogen receptor and in modulating urothelial cell proliferation;Endocrine Related Cancer;2008-03-01